Effect of telmisartan on expression of protein kinase C-α in kidneys of diabetic mice

Acta Pharmacologica Sinica

Volumn 28, Issue 6, 2007, Pages 829-838

  Yao, Li Jun ^a   Wang, Jian Qing ^a   Zhao, Hong ^a   Liu, Jian She ^a   Deng, An Guo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetic nephropathy; Kidney; Mouse; Protein kinases C ; Telmisartan

Indexed keywords

PROTEIN KINASE C ALPHA; STREPTOZOCIN; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME LOCALIZATION; GLOMERULUS EPITHELIUM; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; RENAL PROTECTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PROTEIN KINASE C-ALPHA; RANDOM ALLOCATION; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34249322014     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00541.x     Document Type: Article

References (30)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001 414 : 813 20.
2. Haller H. Postprandial glucose and vascular disease. Diabet Med, 1997 14 : S50 6.
3. Meier M, King GL. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med, 2000 5 : 173 85.
4. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, et al. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int, 1999 56 : 1737 50.
5. Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, et al. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway. Diabetes, 2004 53 : 2921 30.
6. Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-α-deficient diabetic mice. Diabetes, 2004 53 : 2101 9.
7. Yao L, Huang DY, Pfaff IL, Nie X, Leitges M, Vallon V. Evidence for a role of protein kinase C alpha in urine concentration. Am J Physiol Renal Physiol, 2004 287 : F299 304.
8. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. The key role of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Ren Fail, 2001 23 : 471 81.
9. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes, 2005 54 : 1626 34.
10. Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol, 2003 23 : 532 43.
11. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol, 2001 12 : 993 1000.
12. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes, 2002 51 : 3090 4.
13. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int, 2004 65 : 2003 17.
14. Cha DR, Kim NH, Yoon JW, Jo SK, Cho WY, Kim HK, et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int Suppl, 2000 77 : S104 12.
15. Williams B, Gallacher B, Patel H, Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997 46 : 1497 503.
16. Hoshi S, Nomoto K, Kuromitsu J, Tomari S, Nagata M. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun, 2002 290 : 177 84.
17. Lindschau C, Quass P, Menne J, Guler F, Fiebeler A, Leitges M, et al. Glucose-induced TGF-β1 and TGF-β receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-α. Hypertension, 2003 42 : 335 41.
18. Niimi Y, Mochida S, Matsui A, Inao M, Fujiwara K. PKC- and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation. Hepatol Res, 2001 21 : 261 7.
19. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest, 2004 34 : 785 96.
20. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, et al. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy-rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study. J Int Med Res, 2005 33 : 677 86.
21. Wienen W, Richard S, Champeroux P, Audeval-Gerard C. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. J Renin Angiotensin Aldosterone Syst, 2001 2 : 31 6.
22. Redling S, Pfaff IL, Leitges M, Vallon V. Immunolocalization of protein kinase C isoenzymes α, βI, βII, δ, and ζ in mouse kidney. Am J Physiol Renal Physiol, 2004 287 : 289 98.
23. Pfaff IL, Wagner HJ, Vallon V. Immunolocalization of protein kinase C isoenzymes α, βI and βII in rat kidney. J Am Soc Nephrol, 1999 10 : 1861 73.
24. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 1992 258 : 607 14.
25. Karim Z, Defontaine N, Paillard M, Poggioli J. Protein kinase C isoforms in rat kidney proximal tubule: acute effect of angiotensin II. Am J Physiol Cell Physiol, 1995 269 : 134 40.
26. Khundmiri SJ, Dean WL, McLeish KR, Lederer ED. Parathyroid hormone-mediated regulation of Na+-K+-ATPase requires ERK-dependent translocation of protein kinase Calpha. J Biol Chem, 2005 280 : 8705 13.
27. Liang M, Knox FG. Nitric oxide activates PKC-alpha and inhibits Na+-K+-ATPase in opossum kidney cells. Am J Physiol, 1999 277 : F859 65.
28. Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front Biosci, 2005 10 : 2257 62.
29. Hryciw DH, Pollock CA, Poronnik P. PKC-alpha-mediated remodeling of the actin cytoskeleton is involved in constitutive albumin uptake by proximal tubule cells. Am J Physiol Renal Physiol, 2005 288 : F1227 35.
30. Malhotra A, Kang BP, Cheung S, Opawumi D, Meggs LG. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes, 2001 50 : 1918 26.